Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.550
-0.100 (-2.15%)
At close: Dec 5, 2025, 4:00 PM EST
4.600
+0.050 (1.10%)
After-hours: Dec 5, 2025, 7:25 PM EST

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
1216919211014252
Upgrade
Market Cap Growth
30.84%-63.84%75.03%-23.01%174.06%-
Upgrade
Enterprise Value
10557186789543
Upgrade
Last Close Price
4.555.0318.7013.4317.587.54
Upgrade
PB Ratio
6.987.46-24.763.873.206.89
Upgrade
P/TBV Ratio
9.177.46-3.873.206.89
Upgrade
Quick Ratio
4.092.721.353.6930.3313.96
Upgrade
Current Ratio
4.603.592.394.6830.5414.04
Upgrade
Return on Equity (ROE)
-246.14%-3159.09%-546.40%-69.57%-55.68%-180.82%
Upgrade
Return on Assets (ROA)
-105.88%-138.26%-121.77%-38.88%-33.58%-89.86%
Upgrade
Return on Capital (ROIC)
-165.21%-2143.41%-273.63%-43.79%-34.92%-126.89%
Upgrade
Return on Capital Employed (ROCE)
-198.60%-265.80%-759.60%-90.10%-32.70%-88.10%
Upgrade
Earnings Yield
-20.64%-35.43%-29.29%-23.10%-10.17%-10.51%
Upgrade
Buyback Yield / Dilution
-61.36%-35.60%-10.55%-7.03%-20.88%-2132.36%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q